Prenatal perfluorooctanoic sulfonate exposure is associated with polycystic ovary syndrome-like and related traits in female offspring mice
Molecular and Cellular Endocrinology · 2026
DOI: 10.1016/j.mce.2025.112707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026. Verfasst von C Urrutia-Lopez und 13 weiteren Autor:innen. Beteiligte Einrichtung: PhD Graduate Program in Experimental Biology, Metropolitan Autonomous University-Iztapalapa Campus, Mexico City, Mexico. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Fluorocarbons, Prenatal Exposure Delayed Effects, Alkanesulfonic Acids. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Universidad Autónoma Metropolitana, Metropolitan Autonomous University Iztapalapa Campus Biological and Health Sciences, SECIHTI.
Abstract (Originalsprache)
Polycystic Ovary Syndrome (PCOS), is the most common female endocrine disorder affecting women of reproductive age. Its prevalence is estimated to be up to 13 % worldwide. This heterogeneous clinical condition is characterized by marked clinical and/or biochemical hyperandrogenism, ovulatory dysfunction, and frequent development of polycystic ovaries. Several studies have focused on the relationship between endocrine-disrupting pollutants and PCOS development. Perfluorooctanesulfonate (PFOS) is ubiquitously detected in the environment. Exposure to endocrine-disrupting chemicals, including PFOS, during early fetal development may lead to alterations similar to the PCOS phenotype. Using mice as a model, we compared the effects of prenatal exposure to PFOS or dihydrotestosterone (a model of PCOS induction). After analyzing steroid status, we detected delayed pubertal onset accompanied by increased testosterone concentrations in adulthood, as well as altered estrous cycles with a longer metestrus phase. At this point, two of three Rotterdam criteria have been confirmed as PCOS features. Finally, we identified endocrine disruption in the ovaries from adult females prenatally exposed to PFOS, as evidenced by altered expression of genes involved in steroidogenesis pathways, as well as altered expression of gonadotropin hormone receptors, and Amh signaling. These data support a role of PFOS in endocrine disruption and in promoting development of PCOS symptom development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PhD Graduate Program in Experimental Biology, Metropolitan Autonomous University-Iztapalapa Campus, Mexico City, Mexico.
- Department of Health Sciences, Metropolitan Autonomous University-Iztapalapa Campus, Mexico City, Mexico.
- Genetics Research and Environmental Toxicology Unit, Faculty of Higher Education, National Autonomous University of Mexico, Mexico City, Mexico.
- Department of Basic Research, National Institute of Cancerology, Mexico City, Mexico.
- Protein Structure Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.
- Department of Reproductive Biology, Metropolitan Autonomous University-Iztapalapa Campus, Mexico City, Mexico.
Förderung
- Universidad Autónoma Metropolitana
- Metropolitan Autonomous University Iztapalapa Campus Biological and Health Sciences
- SECIHTI
Zitieren
APA
Urrutia-Lopez, C., González-Carranza, L., Barajas-Salinas, A., Bonilla, E., Rodriguez-Mercado, J. J., Aviles, A., Langley, E., Reyes-Grajeda, J. P., Casillas, F., Lopez, A., Casas, E., Betancourt, M., González-Torres, M. C., & Bahena-Ocampo, I. (2026). Prenatal perfluorooctanoic sulfonate exposure is associated with polycystic ovary syndrome-like and related traits in female offspring mice. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2025.112707
Vancouver
Urrutia-Lopez C, González-Carranza L, Barajas-Salinas A, Bonilla E, Rodriguez-Mercado JJ, Aviles A, et al. Prenatal perfluorooctanoic sulfonate exposure is associated with polycystic ovary syndrome-like and related traits in female offspring mice. Molecular and Cellular Endocrinology. 2026. doi:10.1016/j.mce.2025.112707
BibTeX
@article{UrrutiaLopez2026,
author = {Urrutia-Lopez, C and González-Carranza, L and Barajas-Salinas, A and Bonilla, E and Rodriguez-Mercado, J J and Aviles, A and Langley, E and Reyes-Grajeda, J P and Casillas, F and Lopez, A and Casas, E and Betancourt, M and González-Torres, M C and Bahena-Ocampo, I},
title = {Prenatal perfluorooctanoic sulfonate exposure is associated with polycystic ovary syndrome-like and related traits in female offspring mice},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
doi = {10.1016/j.mce.2025.112707}
}
EUVIMED